Physician profile
Andreas Boker
NPI 1306972120
$2,823.64
in general payments reported to CMS, 2019-2025
26 companies · $796 in 2025
The $796 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2021: $110 · 2022: $891 · 2023: $613 · 2024: $218 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,626.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $395.21 | 2021-2025 | Dysport |
| Incyte Corporation | $387.86 | 2022-2025 | Opzelura |
| Abbvie INC. | $373.34 | 2022-2025 | Botox, Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $278.73 | 2019-2024 | Tremfya |
| Arcutis Biotherapeutics, INC. | $153.86 | 2023-2025 | Zoryve |
| Pfizer INC. | $151.06 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $125.41 | 2022-2025 | Dupixent |
| Janssen Scientific Affairs, LLC | $124.05 | 2019 | |
| Genzyme Corporation | $78.63 | 2022-2023 | |
| Lilly USA, LLC | $69.99 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Epi Health, LLC | $63.28 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $58.00 | 2022-2024 | Jublia, Cabtreo |
| Botanix Sb INC | $57.14 | 2025 | Sofdra |
| Organon LLC | $57.13 | 2025 | |
| Ucb, INC. | $55.66 | 2022-2025 | Bimzelx |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $54.72 | 2022-2025 | |
| Dermavant Sciences, INC. | $53.54 | 2022-2023 | Vtama |
| Leo Pharma INC. | $49.20 | 2024-2025 | Adbry |
| Mayne Pharma Commercial LLC | $45.70 | 2022-2025 | |
| Almirall LLC | $41.13 | 2022 | |
| Verrica Pharmaceuticals INC. | $32.30 | 2025 | Ycanth |
| Amgen INC. | $30.56 | 2025 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $30.04 | 2025 | Sotyktu |
| Allergan, INC. | $21.94 | 2022 | |
| Sun Pharmaceutical Industries INC. | $19.98 | 2023 | Winlevi, Absorica Ld |
| Strata Skin Sciences, INC. | $15.18 | 2024 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreas Boker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.